PDE4 Inhibition and Inflammatory Bowel Disease: A Novel Therapeutic Avenue

By Spadaccini Marco   D’Alessio Silvia   Peyrin-Biroulet Laurent   Danese Silvio  

International Journal of Molecular Sciences, Vol. 18, Iss. 6, 2017-06 ,pp. : 1276-1276

MDPI

Access to resources Recommend Favorite

2-(2-Phenylethyl)-4H-chromen-4-one Derivatives from the Resinous Wood of Aquilaria sinensis with Anti-Inflammatory Effects in LPS-Induced Macrophages

By Wang Sin-Ling   Tsai Yun-Chen   Fu Shu-Ling   Cheng Ming-Jen   Chung Mei-Ing   Chen Jih-Jung  

Molecules, Vol. 23, Iss. 2, 2018-01 ,pp. : 289-289

MDPI

Access to resources Recommend Favorite

Natural Products as a Source of Anti-Inflammatory Agents Associated with Inflammatory Bowel Disease

By Debnath Trishna   Kim Da Hye   Lim Beong Ou  

Molecules, Vol. 18, Iss. 6, 2013-06 ,pp. : 7253-7270

MDPI

Access to resources Recommend Favorite

Anti-Inflammatory Activity of Fruit Fractions in Vitro, Mediated through Toll-Like Receptor 4 and 2 in the Context of Inflammatory Bowel Disease

By Nasef Noha Ahmed   Mehta Sunali   Murray Pamela   Marlow Gareth   Ferguson Lynnette R.  

Nutrients, Vol. 6, Iss. 11, 2014-11 ,pp. : 5265-5279

MDPI

Access to resources Recommend Favorite

Functional Testing of SLC26A4 Variants—Clinical and Molecular Analysis of a Cohort with Enlarged Vestibular Aqueduct from Austria

By Roesch Sebastian   Bernardinelli Emanuele   Nofziger Charity   Tóth Miklós   Patsch Wolfgang   Rasp Gerd   Paulmichl Markus   Dossena Silvia  

International Journal of Molecular Sciences, Vol. 19, Iss. 1, 2018-01 ,pp. : 209-209

MDPI

Access to resources Recommend Favorite